Involvement of DT-diaphorase (EC 1.6.99.2) in the DNA cross-linking and sequence selectivity of the bioreductive anti-tumour agent E09
1997

DT-diaphorase and DNA Damage from E09

publication Evidence: moderate

Author Information

Author(s): SM Bailey, MD Wyatt, F Friedlos, JA Hartley, RJ Knox, AD Lewis, P Workman

Primary Institution: CRC Department of Medical Oncology, CRC Beatson Laboratories

Hypothesis

The study investigates the role of DT-diaphorase in the DNA damage induced by the bioreductive anti-tumor agent E09.

Conclusion

The study demonstrates that E09 induces DNA damage in intact cells, with DT-diaphorase playing a significant role in this process.

Supporting Evidence

  • E09 was shown to induce both DNA strand breaks and interstrand cross-links in cancer cells.
  • DT-diaphorase activity correlates with sensitivity to E09 in various cell lines.
  • Under hypoxic conditions, DNA damage from E09 was significantly increased in certain cell lines.

Takeaway

E09 is a drug that can damage DNA in cancer cells, and an enzyme called DT-diaphorase helps activate it to do this.

Methodology

The study used clonogenic assays, DNA alkaline filter elution, and cell-free assays to examine DNA damage and the role of DT-diaphorase.

Limitations

The precise identity of the cytotoxic species remains undetermined, and the study primarily focuses on specific cell lines.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication